AGREEMENT
EXHIBIT A
AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need to be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Kalvista Pharmaceuticals, Inc.
Date: December 30, 2022 | XXXXXXX LIFE SCIENCES PUBLIC FUND, L.P. | |||||
By: FHMLSP, L.P., its General Partner | ||||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLSP, L.P. | |||||
By: FHMLSP, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLSP, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | XXXXXXX LIFE SCIENCES X, L.P. | |||||
By: FHMLS X, L.P., its General Partner | ||||||
By: FHMLS X, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLS X, L.P. | |||||
By: FHMLS X, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLS X, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer |
Date: December 30, 2022 |
XXXXXXX LIFE SCIENCES PUBLIC OVERAGE FUND, L.P. | |||||
By: FHMLSP Overage, L.P., its General Partner | ||||||
By: FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 |
FHMLSP OVERAGE, L.P. | |||||
By FHMLSP Overage, L.L.C., its General Partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 |
FHMLSP OVERAGE, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | XXXXXXX LIFE SCIENCES XI, L.P. | |||||
By FHMLS XI, L.P., its general partner | ||||||
By FHMLS XI, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLS XI, L.P. | |||||
By FHMLS XI, L.L.C., its general partner | ||||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | FHMLS XI, L.L.C. | |||||
By: | /s/ Xxxxx X. Xxxxxx | |||||
Xxxxx X. Xxxxxx, Chief Financial Officer | ||||||
Date: December 30, 2022 | By: | * | ||||
Xxxxx X. Xxxxxx |
Page 2
Date: December 30, 2022 | By: | * | ||||
Xxxxxxx X. Xxxxx | ||||||
Date: December 30, 2022 | By: | ** | ||||
Xxxxxx Xxx | ||||||
Date: December 30, 2022 | By: | ** | ||||
Xxxxx Xxxxx | ||||||
Date: December 30, 2022 | By: | *** | ||||
Xxxxxx Xxxxx | ||||||
Date: December 30, 2022 | By: | /s/ Xxxxx X. Xxxxxx | ||||
Xxxxx X. Xxxxxx, as Attorney-in-Fact |
* | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on February 24, 2017. |
** | This Agreement was executed by Xxxxx X. Xxxxxx on behalf of the individuals listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021. |
*** | This Schedule 13D was executed by Xxxxx X. Xxxxxx on behalf of the individual listed above pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022. |
Page 3